# Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

> **NCT07337850** · — · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 60 (estimated)

## Conditions studied

- Gall Bladder Cancer
- Intrahepatic Cholangiocarcinoma (Icc)

## Interventions

- **DIAGNOSTIC_TEST:** gallium-68-Fibroblast Activation Protein Inhibitor

## Key facts

- **NCT ID:** NCT07337850
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-25
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07337850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07337850, "Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07337850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*